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Experimental modulation of capsule size is an important technique for the study of the virulence of the encapsulated pathogen 
Cryptococcus neoformans. In this paper, we summarize the techniques available for experimental modulation of capsule size in this yeast and 
describe improved methods to induce capsule size changes. The response of the yeast to the various stimuli is highly dependent on the 
cryptococcal strain. A high CO2 atmosphere and a low iron concentration have been used classically to increase capsule size. 
Unfortunately, these stimuli are not reliable for inducing capsular enlargement in all strains. Recently we have identified new and simpler 
conditions for inducing capsule enlargement that consistently elicited this effect. Specifically, we noted that mammalian serum or diluted 
Sabouraud broth in MOPS buffer pH 7.3 efficiently induced capsule growth. Media that slowed the growth rate of the yeast correlated 





Microbial capsules are structures found surrounding the cell body 
that confer particular characteristics to encapsulated organisms. 
In the case of the pathogenic fungus Cryptococcus neoformans, the 
capsule is an important virulence factor (see review in (1)). The 
C. neoformans capsule is composed of at least two polysaccharides 
glucuronoxylomannan and galactoxylomannan, and a much 
smaller proportion of mannoprotein (see review in (2)). This 
polysaccharide capsule has a large number of effects on the host, 
such as complement activation and depletion, Ab 
unresponsiveness, inhibition of leukocyte migration and 
inhibition of phagocytosis (3-9).  
 
One of the characteristics of cryptococcal cells is great variation 
in capsule size depending on the environmental conditions. 
During in vitro culture conditions (10) the size of the capsule is 
usually small, although capsular enlargement can be induced by 
several factors, including high CO2 and low iron (11, 12). During 
mammalian infection, the size of the capsule increases 
dramatically (13-16), and it is thought that this phenomenon is 
necessary for cryptococcal pathogenesis (11). Hence, modulation 
of capsule size is an important subject of investigation for the Zaragoza and Casadevall     
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cryptococcal field. To date, the mechanism of capsule growth 
remains poorly characterized.  
 
The purpose of this paper is to review the different ways of 
manipulating capsule size and to highlight the options and 
limitations available to cryptococcal investigators who plan to 
manipulate the size of a cryptococcal strain. In particularly, we 
will review the great variability in the behavior of strains with 
different genetic backgrounds and the heterogeneity in the 
response in the same strain. We also suggest an experimental 
roadmap to identify the proper conditions to induce capsule size 
of a particular C. neoformans strain. 
 
METHODS AND MATERIALS 
 
Yeast strain and growth conditions 
 
The serotype A C. neoformans strain H99 was kindly provided by 
Dr. John Perfect (Durham, NC) and used for capsule growth 
experiments. The yeast cells were grown overnight in 10 ml of 
acid Sabouraud medium (DifcoTM, Catalogue number 238130, 
Sparks, MD) at 30oC with moderate shaking (150 r.p.m), 
collected in the logarithmic phase of growth by centrifugation (5 
minutes at 1200 r.p.m. at room temperature), washed twice with 
PBS (137 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, 8.5 mM 
Na2HPO4) and incubated in the capsule growth inducing media 
overnight at 37oC. The cells were placed in six-wells polystyrene 
plates at a cell density of 5 x 106-107 cells/ml in the designated 
media (listed in Table 1) and capsule induction was performed 
for 18-24 hours. 
 
India Ink staining and light microscopy 
 
To observe and measure the size of the capsule, 10 µL of a cell 
suspension were mixed with an India Ink drop (Becton 
Dickinson, NJ, Cat. Number 261194) and observed in an 
Olympus AX70 microscope. Pictures were taken with a 
QImaging Retiga 1300 digital camera using the QCapture Suite 
V2.46 software (QImaging, Burnaby BC, Canada), and processed 
with Adobe Photoshop 7.0 for windows (San Jose, CA). At least 
five different fields were randomly chosen and photographed, 
and 40 to 60 cells were analyzed.  
 
Measurement of capsule volume 
 
To calculate the capsule volume, the diameter of the whole cell 
and the cell body were each measured with Adobe Photoshop 7.0 
and capsule volume was defined as the difference between the 
volume of the whole cell (yeast cell + capsule) and the volume of 
the cell body (as limited by the cell wall). Volumes were 
calculated using the equation for volume of a sphere as 
(4π/3)(D/2)3. Between 15 and 40 cells were measured for each 
determination. For statistical analysis, t-test was used with Unistat 
5.5 software for Excel. 
 
RESULTS AND DISCUSSION 
 
Capsule size in the ecological niches of C. 
neoformans 
 
C. neoformans is a pathogenic yeast that is acquired from the 
environment during mammalian infection. This organism can be 
isolated from several environmental niches and is commonly 
found in pigeon excreta, soils, and some trees (see review in (1)). 
For environmental isolates, the size of the capsule is uniformly 
small. During in vitro growth conditions in the media commonly 
used in research laboratories (e.g. Sabouraud medium), the size of 
the capsule is usually small (10). This is in contrast with the 
situation found during infection whereby cells with very large 
capsules are commonly found in tissue (13-16). When cells infect 
the host, there is a rapid increase in capsule size (17). This 
observation suggests the importance of the environmental 
conditions in determining the size of the cryptococcal capsule. In 
the following sections, we summarize and discuss some factors 
that influence capsule size and their interplay in laboratory 
conditions (see Fig. 1 for a summary). 
 
Fig. 1: Scheme of the factors that influence capsule size in C. neoformans. 
The diagram summarizes the main factors involved in the modulation of capsule 
size in C. neoformans. In the upper part we represent factors that increase capsule 
size, and in the lower part, factors that inhibit capsule growth. Bar on left panel 
denotes 10 microns and applies also for panel on the right. 
 
Classical stimuli used to increase capsule size 
 
The size of the capsule of C. neoformans in most laboratory media 
is small, and ranges between 2-4 microns in transversal length, 
without considering the distance between the cell wall. Similarly, 
organisms recovered from the environment usually have small 
capsules. In the late fifties, Littman formulated a mineral medium 
in which the growth of the organisms was accompanied by 
capsule enlargement (10). The composition of this medium was 
based on the nutrients that the yeast was likely to have available 
in physiological fluids, such as the cerebrospinal fluid. That study 
highlighted the importance of certain nutrients in determining the 
size of the capsule, and identified several amino acids, vitamins, 
and carbon sources that contributed to this process. However, 
this method has not been extensively used to induce capsule size, 
possibly because it is not successful with all strains. Several Zaragoza and Casadevall     
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decades later, Granger et al. identified CO2 as an inducing factor 
for capsule growth (11). That study used strain H99. It showed, 
when incubated in DMEM medium i n  a n  a t m o s p h e r e  r i c h  i n  
CO2, induced capsule growth. This observation had potentially 
important physiological implications because it identified a 
product of mammalian respiration as a stimulus for capsule 
growth. Consequently, CO2 is one of the most commonly used 
stimuli to manipulate capsule size. However, not all strains 
responded to CO2 with increased capsule growth (18). In 1993, 
Vartivarian  et al.  observed that a low iron concentration also 
induced capsule growth (12). This medium (known as LIM for 
limited iron medium) has been extensively used in the literature 
to induce capsule size. More recently, we described mammalian 
serum as a potent activator of capsule growth (18).  
 
Other factors that affect capsule size 
 
Capsule growth is affected by a variety of factors, such as pH, 
osmolarity, carbon source, nutrient concentration and 
temperature. Alkaline conditions facilitate capsule growth (11, 18-
21), although a basic pH is not sufficient to mediate this effect. 
Increasing the pH of Sabouraud medium does not enhance 
capsule growth (18). High osmolarity may block capsule growth 
since high glucose concentrations inhibit capsule growth (21), 
and although this effect does not apply to any solute (22), sodium 
chloride produces the same effect (21, 22). Finally, temperature 
seems to have an effect on the size of the cell. This can affect the 
size of the capsule (the diameter of the cell is used in deriving the 
size of the capsule). However, temperature alone does not affect 
the relative size of the capsule (18, 23). 
 
Problems with the reproducibility 
 
One of the problems of the cryptococcal field is that strain 
capsule size and the enlargement phenomenon is poorly 
reproducible from laboratory to laboratory. Consequently, this 
effect has not been studied extensively despite its association 
with virulence. Heterogeneity in the response presumably reflects 
the genetic background, and also the complexity in the interplay 
between the different inducing factors. For example, both CO2 
and serum are very effective as inducing factors, but only in 
specific media (18). Neither serum nor CO2 are able to induce 
capsule growth in media that is rich in nutrients, like Sabouraud 
media, and they require that the yeast is placed in either DME or 
PBS, respectively, to induce capsule growth (18). This implies 
that capsule growth is a highly complex phenomenon that is not 
determined by a unique factor. 
 
There is great variation between different strains (inter-strain 
heterogeneity) in the response to the different stimuli used for 
inducing capsule growth (18). Stimuli that produce capsule 
enlargement in some strains do not produce it in others. This 
variability adds more complexity to this phenomenon. For 
example, the capsular growth induction by CO2 or iron may 
differ from strain-to-strain (12, 18). The reason for this inter-
strain heterogeneity is not known, but most probably it is due to 
genetic differences between the strains. Consequently, for a given 
strain one must evaluate several media empirically to ascertain the 
best conditions for achieving capsule growth. Furthermore, 
certain strains demonstrate intra-strain heterogeneity in the 
response such that all cells may not respond in the same manner 
(11, 17-18). For instance, it has been reported that when strain 
H99 is in the lung, there is a high heterogeneity in the size of the 
cells and capsules of the yeast (17). Similar heterogeneity was also 
reported for strain 24067 in vitro (18). In the case of strain 24067, 
the heterogeneity is probably due to a different behavior of the 
buds that emerge during the incubation in the inducing medium 
(18). The mechanisms responsible for intra- and inter-strain 
heterogeneity are not known, but it is likely that an explanation 
includes genetic differences combined with growth differences 
for individual cells in the medium used (18). Alternatively, intra-
strain heterogeneity could reflect a phenotypic-switching 
phenomenon that is manifested at the cellular level. 
 
New media able to induce capsule size 
 
During our studies of C. neoformans biology, we serendipitously 
discovered that yeast cells of strain H99 placed in a Sabouraud 
medium diluted 10 times with H2O developed large capsules (Fig. 
2). That result suggested that capsule enlargement was related to 
the cell growth rate. In addition, we observed that when 
Sabouraud medium was diluted, not in water, but in buffer with 
basic pH, such as MOPS, HEPES or PBS, the increase in capsule 
size was more noticeable (Fig. 2). Moreover, increasing the pH of 
diluted Sabouraud in water by addition of some drops of NaOH 
enhanced the efficiency of the process (Fig. 2). 
 
Fig. 2: Capsule growth in different media containing diluted Sabouraud. 
H99 cells were grown in Sabouraud medium, collected in the logarithmic phase of 
growth, washed and transferred to 2 ml of media indicated in each case. In some 
cases, a few drops of NaOH were used to manipulate the pH, while in other 
experiments MOPS or HEPES buffer were used. The cells were incubated 
overnight at 37oC as described in material and methods. Bar on first panel 
denotes 10 microns and applies also for the rest of the panels. 
 
The effect was observed by six hours and appeared complete by 
24 h. Longer incubations did not significantly change the size of 
the capsule. Among the media evaluated, the biggest capsules 
were observed when pH was buffered with 50 mM MOPS pH 
7.3, and was associated with noticeably slower growth (data not 
shown). These results provide new experimental conditions to 
increase capsule size in the absence of serum or CO2 incubators. Zaragoza and Casadevall     
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Comparison of the efficiency of diluted Sabouraud in MOPS 
buffer, with CO2 and serum to previously established methods 
revealed that our methods were more consistent in promoting 
capsule growth (Fig. 3). 
 
Fig. 3: Comparison of capsule growth on diluted Sabouraud, serum and 
CO2. H99 cells were grown in Sabouraud overnight and then transferred to the 
following media: Diluted Sabouraud (1/10) in 50 mM MOPS buffer (pH 7.3), or 
10% FBS (in PBS) or in DME in the presence of an atmosphere of 10% CO2. 
The cells were incubated in these media overnight at 37oC. A) Picture of a 
representative cell in an India Ink suspension. The bar in the first panel denotes 
10 microns, and this scale applies to the rest of pictures. B) Measurement of the 
capsule size for the samples described above. The size of the capsule was 
expressed as the total capsule volume. P value for all comparisons was below 
0.001. 
 
Capsule size during infection 
 
The increase of capsule size during infection is believed to be 
biologically significant because of the virulence-enhancing 
properties of capsular polysaccharide. It is thought that this 
increase in capsule size is necessary for the virulence of the yeast 
since mutants that are unable to do this are not as virulent as wild 
type strains (11, 24-25). This increase in capsule size is noticeable 
after several hours of infection (17). It is interesting that after 
several days of infection, the increase in capsule size is 
accompanied by an increase in the size of both the cell and the 
capsule, which results in giant forms of the yeast, whose role in 
virulence is unknown (17). Finally, the increase in capsule size is 
dependent on the organ of infection, with capsules being larger 
in the lung than in the brain (16). This reflects the importance of 
the environment on the size of the capsule. With regard to 
organic substances, both coagulase plasma (26) and mammalian 
sera (18) have been reported to be effective in inducing capsule 
growth. 
 
Physiological meaning of the factors that induce 
capsule growth 
 
We have described several new stimuli for capsule growth. 
However, the fact that this phenomenon occurs only in certain 
conditions raises the question of what factors are specifically 
responsible for the effect. In the case of CO2 induction, capsule 
growth appears to resemble the in vivo situation that the yeast cells 
encounter in the lung, which is the first organ infected after 
inhalation of the infectious particles. Limited iron medium is 
another stimulus that can be used to induce capsule growth. The 
mechanism by which iron limitation induces capsule growth 
remains unknown. Iron regulates the production of some 
virulence factors in bacteria (27, 28), and regulation of Fe 
concentration in physiological fluids by the host could affect the 
virulence of these organisms. It has been suggested that if iron 
uptake is mediated through the capsule, an increase in capsule 
size would be a response to transport iron more efficiently, but 
the same authors argued that this was unlikely since acapsular 
mutants grow normally during iron limitation conditions (12). 
Serum is known to contain iron-binding chelators and the effect 
in serum could reflect lack of iron, which in turn would affect 
growth. However, serum-induced capsule growth was not 
inhibited by addition of iron to the medium (18), indicating that 
the inducing signal is different. Since C. neoformans in a 
mammalian host would encounter serum components in the 
course of infection, the phenomenon of serum-induced capsular 
growth may reflect the stimulus that induces capsule size during 
pathogenesis. Concerning the other media described in this 
paper, such as diluted Sabouraud medium in buffers with basic 
pH, we believe that there is a decrease in the growth rate of the 
yeast, which could trigger capsule growth, possibly as a 
consequence of a stress response. This result, if validated by 
subsequent experimental work, would link capsule growth to cell 
growth. Consistent with this hypothesis is the fact that capsule 
growth is enhanced by an alkaline pH, a condition in which 
fungal cells grow more slowly. Finally, and related to the in vivo 
situation, it has been shown that in the lung, the size of the 
capsule is bigger than in the brain (16). Although the cause of this 
phenomenon is not known, the inflammatory response in much 
higher in the lung than in the brain (1), which may slow the 
growth of the yeast in the lung and is also consistent the view 
that capsule growth is correlated with slower replication. In 
addition, brain tissue may contain more iron (16), which could 
promote faster growth. However, it is important to stress that the 
concept that capsule growth is inversely proportional to growth 
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Technical hints to check your favorite strain for capsule growth 
 
In this section we briefly propose a pragmatic scheme to identify the conditions that induce capsule growth for an individual strain (see 
Table 1), and highlight the advantages and disadvantages of each approach. These suggestions must take into consideration that the 
efficiency of the process is highly strain dependent, and the most effective protocol may differ from strain to strain, as already reported 
(18). To induce capsule growth, we suggest first to grow the yeast in liquid Sabouraud medium overnight, washed with sterile PBS, and 
inoculated in 6-wells plates with 2 ml of each media at a cell density of 5 x 106-107 cells/ml. In our hands, the best results were obtained 
when capsule growth was induced at 37oC, although incubation at room temperature and 30oC could also increase capsule size. 
 
•  Diluted Sabouraud. One of the most efficient methods for capsule induction is to incubate the yeast in diluted Sabouraud broth 
in H2O. For increasing the efficiency of these methods one can dilute the Sabouraud medium 10 times in either PBS, MOPS 50 
mM pH 7.3 or HEPES 50 mM pH 7.3. This method is highly efficient at both 30 and 37oC and will produce good results in both 
shaking flasks and culture plates. In our hands this was the most efficient method for inducing capsule growth. The fact that 
neither serum, CO2 nor complex media are required makes this a convenient and powerful new tool to induce capsule size in future 
studies. 
•  Serum. The effect of serum is highly dependent on the medium in which it is diluted. In our hands PBS worked very well as the 
diluent to induce capsule growth. Dilution in other media, such as Sabouraud was not effective. It has been reported that a 10% 
concentration is optimal, but higher concentrations can be used (18). Different mammalian sera can induce this effect, but rat and 
fetal bovine sera seemed to be more effective. When serum is used, best results were observed when the culture plates were 
incubated without agitation at 37oC. 
•  CO2. Incubation of the yeast in a rich atmosphere in CO2 can be used to induce capsule growth. However, induction of capsule 
growth by CO2 was observed only when the cells were incubated in DMEM or RPMI media. It some reports, the medium was 
supplemented with 22 mM NaHCO3, but the conditions when this was required were not established. Consequently, the 
requirement for NaHCO3 needs to be established empirically.  Five and 10% concentrations of CO2 have been reported to be 
effective. In general, the use of a routine laboratory tissue culture CO2 incubator for supplying this atmosphere makes agitation 
impractical. However, incubation without agitation is highly efficient in inducing capsule growth. The requirement of special 
equipment to supply an enriched CO2 atmosphere may limit the use of this method. 
•  Limited iron medium (LIM). A low iron concentration is one of the most common stimuli used to induce capsule growth. Its 
effect is enhanced by combination with the CO2 stimulus (12). In table 1, we have included the composition of the medium as 
originally described (12), although other investigators have modified the composition of this medium (29). Complete depletion of 
iron is achieved by treatment of some of its components with the ion exchange resin Chelex-100 (BioRad). Iron depletion can be 
also performed by addition of 56 µM ethylenediaminedi(ο-hydroxylphenyl acetic acid) (EDDA). Since LIM is a complex medium, 
in many occasions it is convenient to use a control in which iron is added. For iron repletion, one can add 100 µM Fe(III) 
hydroxyethylenediaminetriacetate (FeHEDTA). Although this method has been largely used in the past, the concern that iron is 
not completely eliminated from the medium might introduce uncertainty on its effectiveness when the capsule is not induced. 
 
Table 1: Methods to obtain C. neoformans cells with big capsule 
Inducing factor  Composition and protocol 
Diluted Sabouraud  Dilute Sabouraud (DifcoTM 238230) 1/10 in H2O, or PBS, or 50 mM HEPES (Gibco, 15630-080) or MOPS 
(Sigma, Cat. No M-9381) pH 7.3. Incubate at 37oC. 
CO2  DME (Cellgro by Mediatech Inc., 10-013-CM)  or RPMI (Cellgro by Mediatech Inc.,MT 10-040-CM). 
Inoculate and incubate in CO2 incubators (5 or 10% CO2). If necessary, add 22 mM NaHCO3  (Fisher 
Scientific, S233-500). Incubate at 37oC. 
LIM  LIM (pH 7.4) as described originally (12), contains per liter (all products from Sigma Aldrich), 5 g of glucose 
(G5767), 400 mg of K2HPO4 (P3786), 5 g of asparagine (A0884), 250 mg of CaCl2 · 2H2O (C3881), 0.4 mg of 
thiamine (T4625), 5 mg of CuSO4 (C2857), 2 mg of ZnSO4  · 7H2O (Z4750), 0.01 mg of MnCl2  · 4H2O 
(M3634), 80 mg of MgSO4  · 7 H2O (M5921), 0.46 mg of Na2MoO4 (M1003) and 0.057 mg of boric acid 
(B0394). Incubate yeast at room temperature. 
Serum  10% fetal bovine serum (Gemini BioProducts, Woodland, CA, A37606V) in PBS. Incubate at 37oC. 
 